androstane-3,17-diol has been researched along with Alcohol Drinking in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arias, AJ; Covault, J; Feinn, R; Kranzler, HR; Oncken, C; Pond, T | 1 |
| Abnet, CC; Cross, AJ; Freedman, ND; Guertin, KA; Mayne, ST; Shebl, FM; Troche, JR | 1 |
1 trial(s) available for androstane-3,17-diol and Alcohol Drinking
| Article | Year |
|---|---|
Dutasteride reduces alcohol's sedative effects in men in a human laboratory setting and reduces drinking in the natural environment.
Topics: 5-alpha Reductase Inhibitors; Adult; Alcohol Drinking; Androstane-3,17-diol; Azasteroids; Central Nervous System Depressants; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Dutasteride; Environment; Ethanol; Humans; Male; Middle Aged; Receptors, GABA-A; Young Adult | 2014 |
1 other study(ies) available for androstane-3,17-diol and Alcohol Drinking
| Article | Year |
|---|---|
Alcohol Consumption-Related Metabolites in Relation to Colorectal Cancer and Adenoma: Two Case-Control Studies Using Serum Biomarkers.
Topics: Adenoma; Aged; Alcohol Drinking; Alcoholic Beverages; Androstane-3,17-diol; Bilirubin; Biomarkers; Case-Control Studies; Colorectal Neoplasms; Dipeptides; Ethanol; Fatty Acids, Monounsaturated; Female; Glucuronates; Humans; Linoleic Acid; Male; Middle Aged; Odds Ratio; Palmitic Acids; Peptides, Cyclic | 2016 |